CLOV (Clover Health Investments) Stock Based Compensation: $89 Mil (TTM As of Mar. 2026)


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.26
GF Value $3.99
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Stock Based Compensation?

Clover Health Investments CLOV -2.59% 81 Stock Based Compensation is $89 Mil as of Mar. 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.99 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Clover Health Investments's Stock Based Compensation for the three months ended in Mar. 2026 was $12 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $89 Mil.

Clover Health Investments Stock Based Compensation Related Terms

Clover Health Investments Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Stock Based Compensation Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 163.72 164.31 140.93 114.33 103.66

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.44 26.20 26.11 24.92 12.27
CLOV
81GF Score
Clover Health Investments Corp CLOV
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $89 Mil.

What does a Stock Based Compensation of $89 Mil mean?
Clover Health Investments (CLOV) has a Stock Based Compensation of $89 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Clover Health Investments and its competitors.
Is Clover Health Investments' Stock Based Compensation too high?
Clover Health Investments' current Stock Based Compensation is $89 Mil. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Stock Based Compensation compare to PGNY and ALHC?
Clover Health Investments' Stock Based Compensation of $89 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Plans company?
A good Stock Based Compensation depends on the Healthcare Plans industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Clover Health Investments and its competitors. Clover Health Investments's current Stock Based Compensation is $89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.99, compared to a current price of $5.26 — trading 31.8% above its estimated fair value. The current Stock Based Compensation is $89 Mil. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Stock Based Compensation is $89 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.26 is trading 31.8% above its estimated GF Value™ of $3.99. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

  • Stock Based Compensation: $89 Mil
  • GF Value™: $3.99 vs. price of $5.26 (31.8% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.26
Price
$3.99
GF Value